ronsternMaybe a deliberate attempt to keep the share price down so a deal can be done to the usual mob on the next one or two share offerings!JAWSY:)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%